DORMANT studio
localhost:3000

Opportunity radar

4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05

Showing50 of 30,058
Free-text
CPC starts with (comma sep)
Min fwd citations
Clear
Patent #TitleAssetsIssuedExpiresFwd citesScore
12569557Targeting moDC to enhance vaccine efficacy on mucosal surface🖼🧊📄§2026-03-102039-09-27031
12569552Fusion protein of pentamer and gB of cytomegalovirus, and vaccine containing said fusion protein🖼🧊📄§2026-03-102041-06-08031
12569553Shingles vaccines comprising a TLR9 agonist🖼🧊📄§2026-03-102041-03-09031
12569549Flavivirus vaccine🖼🧊📄§2026-03-102044-01-04031
12569545Method for treating and/or improving inflammatory intestinal disease🖼🧊📄§2026-03-102043-05-24031
12569547Immunogenic compositions against Clostridioides (Clostridium) difficile and methods thereof🖼🧊📄§2026-03-102041-06-17031
12569538DPEP-1 binding compositions and methods of use🖼🧊📄§2026-03-102043-06-05031
12569539Adipocytes over-expressing FFAR4 and use thereof🖼🧊📄§2026-03-102041-05-26031
12569536Macrocyclic peptides for targeted inhibition of autophagy🖼🧊📄§2026-03-102040-01-30031
12569529Natural combination products and methods for regulation of kidney and excretory system function🖼🧊📄§2026-03-102043-08-28031
12569530Tannin-based antiproliferative pharmaceutical🖼🧊📄§2026-03-102044-04-26031
12569527Tetraselmis chuii (T. chuii) for the treatment of male infertility🖼🧊📄§2026-03-102041-07-09031
12569525Gene therapy for treating phenylketonuria🖼🧊📄§2026-03-102042-06-06031
12569521Methods and compositions for treating inflammatory skin disease with recombinant microorganisms🖼🧊📄§2026-03-102044-04-22031
12569517Method for treating osteoarthritis with mesenchymal stem cell exosomes🖼🧊📄§2026-03-102040-02-07031
12569507CAR T-cells for the treatment of bone metastatic cancer🖼🧊📄§2026-03-102041-02-05031
12569510Antiviral prodrugs and pharmaceutical compositions thereof🖼🧊📄§2026-03-102040-09-11031
12569500Combination comprising tricycle compound and use thereof in preparation of medicament for treating HBV🖼🧊📄§2026-03-102041-05-14031
12569496Treatment of cancer with a RAF inhibitor🖼🧊📄§2026-03-102044-01-26031
12569501Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions🖼🧊📄§2026-03-102042-10-13031
12569490Methods for treating testicular and ovarian adrenal rest tumors🖼🧊📄§2026-03-102045-01-31031
12569486Calmodulin inhibitors, CHK2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies🖼🧊📄§2026-03-102044-02-13031
12569476Piperidine urea derivatives for use as inotropic agents🖼🧊📄§2026-03-102045-02-21031
12569473Methods to treat respiratory infection utilizing castanospermine analogs🖼🧊📄§2026-03-102043-07-05031
12569468Use of palovarotene in treatment against HBV virus🖼🧊📄§2026-03-102041-06-01031
12569463Method for treating diabetes🖼🧊📄§2026-03-102042-09-22031
12569459Compositions and methods for treating pulmonary edema or lung inflammation🖼🧊📄§2026-03-102041-03-26031
12569472PPARγ agonists for treatment of kidney disease🖼🧊📄§2026-03-102041-04-27031
12569455Therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome🖼🧊📄§2026-03-102041-02-05031
12570958Single- and multi-chain chimeric antigen receptors🖼🧊📄§2026-03-102038-12-19031
12570975Composition for diagnosis or treatment of a condition associated with increased activity of EIF4E comprising an EIF4E inhibitor🖼🧊📄§2026-03-102040-09-03031
12564613Strains having effects of preventing or treating cancers🖼🧊📄§2026-03-032039-05-08031
12565485Solid forms of 1-((S)-4-((R)-7-(6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro-2-(((s)-1-methylpyrrolidin-2-yl)methoxy)quinazolin-4-yl)-3-methylpiperazin-1-yl)prop-2-en-1-one🖼🧊📄§2026-03-032043-02-03031
12564575Early management, mitigation and prevention of sepsis and sepsis-like syndromes, including neo-natal ARDS due to infection, injury or iatrogenesis🖼🧊📄§2026-03-032042-04-21031
12564202Composition for alleviating, preventing or treating sarcopenia, containing whey protein hydrolysate as active ingredient🖼🧊📄§2026-03-032040-09-25031
12564620Treatment of gulf war illness🖼🧊📄§2026-03-032042-09-15031
12564599Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight🖼🧊📄§2026-03-032040-02-21031
12565660Immunomodulating transgenic plants and related methods🖼🧊📄§2026-03-032044-01-24031
12565649Methods of rescuing stop codons via genetic reassignment with ACE-tRNA🖼🧊📄§2026-03-032043-04-21031
12565533Agonistic CD40 antibodies🖼🧊📄§2026-03-032043-05-25031
12564645Methods for treatment of methylmalonic acidemia🖼🧊📄§2026-03-032039-09-13031
12565522Micropeptide HMMW and application thereof🖼🧊📄§2026-03-032040-11-03031
12564586Kappa opiod receptor antagonists for treating pain-related sleep disorders🖼🧊📄§2026-03-032041-04-09031
12564595Prophylactic and therapeutic pharmaceutical agent for HIV infectious diseases characterized by comprising combination of integrase inhibitor and anti-HIV agent🖼🧊📄§2026-03-032040-11-27031
12564631Phytosphingosine derivatives as adjuvants in immune stimulation🖼🧊📄§2026-03-032041-06-18031
12564576Therapeutic agent for vascular disorder🖼🧊📄§2026-03-032041-05-07031
12564617Methods for modulating macrophage activity🖼🧊📄§2026-03-032041-09-17031
12565531Bispecific fusion protein for tumor treatment🖼🧊📄§2026-03-032040-12-03031
12565488Inhibitors of influenza virus replication🖼🧊📄§2026-03-032039-11-26031
12564568PKC pathway in Parkinson's Disease🖼🧊📄§2026-03-032039-04-05031